Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Clin Infect Dis ; 68(2): 239-246, 2019 01 07.
Artigo em Inglês | MEDLINE | ID: mdl-29901775

RESUMO

Background: Intervention by infectious diseases (ID) physicians improves outcomes for inpatients in Medicare, but patients with other insurance types could fare differently. We assessed whether ID involvement leads to better outcomes among privately insured patients under age 65 years hospitalized with common infections. Methods: We performed a retrospective analysis of administrative claims data from community hospital and postdischarge ambulatory care. Patients were privately insured individuals less than 65 years old with an acute-care stay in 2014 for selected infections, classed as having early (by day 3) or late (after day 3) ID intervention, or none. Key outcomes were mortality, cost, length of the index stay, readmission rate, mortality, and total cost of care over the first 30 days after discharge. Results: Patients managed with early ID involvement had shorter length of stay, lower spending, and lower mortality in the index stay than those patients managed without ID involvement. Relative to late, early ID involvement was associated with shorter length of stay and lower cost. Individuals with early ID intervention during hospitalization had fewer readmissions and lower healthcare payments after discharge. Relative to late, those with early ID intervention experienced lower readmission, lower spending, and lower mortality. Conclusions: Among privately insured patients less than 65 years old, treated in a hospital, early intervention with an ID physician was associated with lower mortality rate and shorter length of stay. Patients who received early ID intervention during their hospital stay were less likely to be readmitted after discharge and had lower total healthcare spending.


Assuntos
Custos de Cuidados de Saúde , Infectologia , Readmissão do Paciente , Estudos de Coortes , Feminino , Hospitais , Humanos , Controle de Infecções/métodos , Masculino , Alta do Paciente , Estudos Retrospectivos , Estados Unidos
2.
Curr Allergy Asthma Rep ; 6(2): 163-70, 2006 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-16566867

RESUMO

The current epidemic of H5N1 highly pathogenic avian influenza in Southeast Asia raises serious concerns that genetic reassortment will result in the next influenza pandemic. There have been 164 confirmed cases of human infection with avian influenza since 1996. In 2004 alone, there were 45 cases of human H5N1 in Vietnam and Thailand, with a mortality rate over 70%. In addition to the potential public health hazard, the current zoonotic epidemic has caused severe economic losses. Efforts must be concentrated on early detection of bird outbreaks with aggressive culling, quarantines, and disinfection. To prepare for and prevent increased human cases, it is essential to improve detection methods and stockpile effective antivirals. Novel therapeutic modalities, including short, interfering RNAs and new vaccine strategies that use plasmid-based genetic systems offer promise, should a pandemic occur.


Assuntos
Virus da Influenza A Subtipo H5N1 , Influenza Aviária/diagnóstico , Influenza Humana/diagnóstico , Animais , Sudeste Asiático/epidemiologia , Surtos de Doenças/veterinária , Humanos , Influenza Aviária/epidemiologia , Influenza Aviária/prevenção & controle , Influenza Aviária/virologia , Influenza Humana/epidemiologia , Influenza Humana/terapia , Influenza Humana/virologia , Aves Domésticas
3.
Curr Infect Dis Rep ; 7(3): 193-199, 2005 May.
Artigo em Inglês | MEDLINE | ID: mdl-15847721

RESUMO

The current epidemic of H5N1 highly pathogenic avian influenza in Southeast Asia raises serious concerns that genetic reassortment will result in the next influenza pandemic. There have been 164 confirmed cases of human infection with avian influenza since 1996. In 2004, there were 45 cases of human H5N1 in Vietnam and Thailand, with a mortality rate more than 70%. In addition to the potential public health hazard, the current zoonotic epidemic has caused severe economic losses. Efforts must be concentrated on early detection of bird outbreaks with aggressive culling, quarantining, and disinfection. To prepare for and prevent an increase in human cases, it is essential to improve detection methods and stockpile effective antivirals. Novel therapeutic modalities, including short-interfering RNAs and new vaccine strategies that use plasmid-based genetic systems, offer promise should a pandemic occur.

4.
J Clin Microbiol ; 42(9): 4405-7, 2004 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-15365057

RESUMO

A Campylobacter species was isolated from blood from a febrile patient with precursor T-cell acute lymphoblastic leukemia, and after antibiotic treatment, a similar bacterium was isolated from blood 37 days later. Although phenotypic testing did not definitively identify the organisms, molecular analysis indicated that they were the same strain of Campylobacter fetus subsp. fetus and were of reptile origin.


Assuntos
Infecções por Campylobacter/transmissão , Campylobacter fetus , Adulto , Animais , Antibacterianos , Infecções por Campylobacter/tratamento farmacológico , Campylobacter fetus/efeitos dos fármacos , Campylobacter fetus/isolamento & purificação , Campylobacter fetus/patogenicidade , Quimioterapia Combinada/farmacologia , Quimioterapia Combinada/uso terapêutico , Humanos , Masculino , Testes de Sensibilidade Microbiana , Dados de Sequência Molecular , Répteis
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA